Ann Eriksson-Dufva

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

F. Piehl, A. Punga, A. Budzianowska, 2022, JAMA neurology.

Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.

F. Piehl, S. Brauner, T. Frisell, 2020, JAMA neurology.